Catalytic Aerobic Photooxidation of Phosphines using Four-coordinated Organoboron Compounds as Photocatalysts
Synlett · 03.09.2024 · 35 (14) · 1698-1702
DOI: 10.1055/a-2233-9431 ↗Kurz gefasst
Fachartikel in der Zeitschrift Synlett, erschienen am 03.09.2024. Verfasst von Liang Xu und 4 weiteren Autor:innen. Die Arbeit nennt 53 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Program for Changjiang Scholars and Innovative Research Team in University, Yangtze River Scholar Research Project of Shihezi University.
Abstract (Originalsprache)
A photooxidation approach to the conversion of phosphines into the corresponding phosphine oxides is reported. By taking advantage of O2 in the air as an oxidant and oxygen source, phosphine oxides were obtained efficiently in moderate to excellent yields. A four-coordinated organoboron compound was used as the photocatalyst to activate O2 to its singlet state. This photooxidation method features mild reaction conditions, broad functional-group tolerance, and a wide substrate scope.
Förderung
- National Natural Science Foundation of China
- Program for Changjiang Scholars and Innovative Research Team in University
- Yangtze River Scholar Research Project of Shihezi University
Zitieren
APA
Xu, L., Song, H., Tang, Y., Wei, L., & Wei, Y. (2024). Catalytic Aerobic Photooxidation of Phosphines using Four-coordinated Organoboron Compounds as Photocatalysts. Synlett, 35(14), 1698-1702. https://doi.org/10.1055/a-2233-9431
Vancouver
Xu L, Song H, Tang Y, Wei L, Wei Y. Catalytic Aerobic Photooxidation of Phosphines using Four-coordinated Organoboron Compounds as Photocatalysts. Synlett. 2024;35(14):1698-1702. doi:10.1055/a-2233-9431
BibTeX
@article{Xu2024,
author = {Xu, Liang and Song, Huanhuan and Tang, Yingru and Wei, Lanfeng and Wei, Yu},
title = {Catalytic Aerobic Photooxidation of Phosphines using Four-coordinated Organoboron Compounds as Photocatalysts},
journal = {Synlett},
year = {2024},
volume = {35},
number = {14},
pages = {1698--1702},
doi = {10.1055/a-2233-9431}
}
EUVIMED